Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Dloc Biosystems Inc. is active in the Chemistry & Materials technology area with 2 pending office actions currently in progress. These actions are distributed across 2 distinct examiners, yet they remain concentrated within 1 distinct art unit. This suggests that while the technical subject matter is consistent enough to stay within one unit, the company is navigating different examiner perspectives for its applications.
BEISNER, WILLIAM H is identified as the busiest examiner for the portfolio, currently handling 1 pending office action. Because the total number of pending actions is 2, the workload is evenly split between the two examiners involved. This distribution requires practitioners to adapt to multiple examination styles even while operating within the same art unit constraints. The lack of examiner concentration means that no single individual's preferences will dictate the entire portfolio's outcome.
The focus on Chemistry & Materials indicates a specific technical niche for the company's filings. With 2 distinct examiners involved, the company must manage two separate prosecution timelines and sets of feedback. The concentration in 1 distinct art unit may provide some consistency in the broad legal standards applied, but the individual examiner assignments will dictate the specific hurdles for each application. Practitioners should coordinate their responses to ensure a cohesive strategy across both pending matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEISNER, WILLIAM H | 1 | 61.9% | +29.0% |
| KIPOUROS, HOLLY MICHAELA | 1 | 69.8% | +21.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18751005 | HUMAN-ON-CHIP OPERATING SYSTEM | BEISNER, WILLIAM H | — |
| 18012547 | DUCT ORGANOID-ON-CHIP | KIPOUROS, HOLLY MICHAELA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18751005 | HUMAN-ON-CHIP OPERATING SYSTEM | BEISNER, WILLIAM H | — |
| 18012547 | DUCT ORGANOID-ON-CHIP | KIPOUROS, HOLLY MICHAELA | — |
| Art Unit | Apps |
|---|---|
| 1799 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18751005 | HUMAN-ON-CHIP OPERATING SYSTEM | BEISNER, WILLIAM H | 1799 | §103§112 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18012547 | DUCT ORGANOID-ON-CHIP | KIPOUROS, HOLLY MICHAELA | 1799 | §102§112 | Non-Final OA | — | Pending | Dec 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDloc Biosystems Inc. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
William H Beisner has the most, with 1 of Dloc Biosystems Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
